Hypoglycemia – a condition in which low blood glucose levels can cause you to feel dizzy, weak, and shaky – can catch you by ...

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes ...

Given the scope of the risk, attention has turned to metabolic hormones that regulate appetite, satiety, and glucose metabolism, particularly glucagon-like peptide-1 (GLP-1).

The addition of glucagon-like peptide-1 receptor agonists to progestin therapy may help reduce endometrial cancer risk among certain women, according to study results.Findings presented at Society ...

The hormone glucagon, which is produced in the pancreas, helps the liver turn stored sugar into energy. Normally, insulin and glucagon work together to regulate blood sugar levels.

A new study found that blocking the activity of the blood sugar regulating hormone, glucagon, improves heart function in mouse models of heart failure. The findings may pave the way to one of the ...

Tests in mice suggest glucagon micelle could be used as a responsive system to prevent the onset of insulin-induced deep hypoglycemia.

Glucagon is a hormone that signals the liver to release glucose into the bloodstream. It's typically given by injection to counteract severe hypoglycemia in people who have diabetes.

Encapsulated glucagon for insulin-induced hypoglycemia dissolves when sugar levels get seriously low (less than 60 milligrams per deciliter, mg/dL), releasing the hormone into the bloodstream and ...

Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes.

WebMD explains how the hormone glucagon helps balance your blood sugar and treat hypoglycemia.

ORLANDO -- Novel dual GLP-1 and glucagon agonist pemvidutide reduced weight and lipids with somewhat less muscle loss than expected, the phase II MOMENTUM trial showed.